Funder: Dept. of the Army -- USAMRAA
Due Dates: June 12, 2026: Pre-application (Preproposal) | September 30, 2026: Full application
Funding Amounts: Up to $5.6M (single PI) or $7.0M (Partnering PI Option) total costs over 4 years; ~2 awards; total program funding ~$12.6M.
Summary: Supports advanced translational breast cancer research projects with high potential for breakthroughs and major impact.
Key Information: Requires two or more breast cancer consumer advocates as integral team members; small-scale clinical trials allowed but not required.